Pension Fund Says It Lost $33.6M Over Pharma Co.'s Actions

By Sydney Price · July 19, 2023, 8:50 PM EDT

In its bid to lead a proposed class action, an Ohio pension fund told a Massachusetts federal court it lost nearly $34 million on its shares of pharmaceutical company Charles River...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Coleman v. Charles River Laboratories International, Inc. et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

May 19, 2023

Recent Articles By Sydney

July 18, 2024
Ocugen Execs Hit With Derivative Suit Over Shoddy Controls
July 15, 2024
Walgreens Investor Sues Over Challenged Pharmacy Division
July 10, 2024
Skin Care Tech Co. Says Suit Shows 'Rough' Year, Not Fraud
July 08, 2024
UnitedHealth Brass Face Investor Suit Over Merger Probe
July 08, 2024
Medical Device Co. SeaStar Sued Over Regulatory Disclosures
July 02, 2024
Pharma Co. Scores Exit In Investor Suit Over Primate Imports
June 06, 2024
Pharma Co. Misled Investors On Seizure Drug Trial, Suit Says
May 15, 2024
UnitedHealth Concealed DOJ Merger Investigation, Suit Says
May 13, 2024
Biogen Investors Seek Class Cert. In Alzheimer's Drug Suit
May 08, 2024
Shockwave Medical Investor Challenges $13B Deal With J&J